Global Microbial Alternative Protein 麻豆原创 Research Report 2023

Publication ID:

PB502238156

Publication Date:

February 8, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Food Processing [2]

Food [3]

Food & Beverages [4]

Description:

Highlights
The global Microbial Alternative Protein market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Microbial Alternative Protein is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Microbial Alternative Protein is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Microbial Alternative Protein include AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), Entomo Farms (Canada), Global Bugs Asia Co., Ltd. (Thailand), Aspire Food Group (U.S.) and Tiny Farms (U.S.), etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microbial Alternative Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Alternative Protein.
The Microbial Alternative Protein market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Microbial Alternative Protein market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial Alternative Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AgriProtein (South Africa)
Ynsect (France)
Enterra Feed Corporation (Canada)
Protix (The Netherlands)
Proti-Farm Holding NV (The Netherlands)
Entomo Farms (Canada)
Global Bugs Asia Co., Ltd. (Thailand)
Aspire Food Group (U.S.)
Tiny Farms (U.S.)
Segment by Type
Emerging Alternative Protein
Adolescent Alternative Protein
Matured Alternative Protein
Segment by Application
Food
Feed
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microbial Alternative Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microbial Alternative Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Microbial Alternative Protein 麻豆原创 Overview
1.1 Product Overview and Scope of Microbial Alternative Protein
1.2 Microbial Alternative Protein Segment by Type
1.2.1 Global Microbial Alternative Protein 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Emerging Alternative Protein
1.2.3 Adolescent Alternative Protein
1.2.4 Matured Alternative Protein
1.3 Microbial Alternative Protein Segment by Application
1.3.1 Global Microbial Alternative Protein 麻豆原创 Value by Application: (2023-2029)
1.3.2 Food
1.3.3 Feed
1.3.4 Others
1.4 Global Microbial Alternative Protein 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Microbial Alternative Protein Revenue 2018-2029
1.4.2 Global Microbial Alternative Protein Sales 2018-2029
1.4.3 Global Microbial Alternative Protein 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Microbial Alternative Protein 麻豆原创 Competition by Manufacturers
2.1 Global Microbial Alternative Protein Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Microbial Alternative Protein Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Microbial Alternative Protein Average Price by Manufacturers (2018-2023)
2.4 Global Microbial Alternative Protein Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Microbial Alternative Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microbial Alternative Protein, Product Type & Application
2.7 Microbial Alternative Protein 麻豆原创 Competitive Situation and Trends
2.7.1 Microbial Alternative Protein 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microbial Alternative Protein Players 麻豆原创 Share by Revenue
2.7.3 Global Microbial Alternative Protein 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microbial Alternative Protein Retrospective 麻豆原创 Scenario by Region
3.1 Global Microbial Alternative Protein 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Microbial Alternative Protein Global Microbial Alternative Protein Sales by Region: 2018-2029
3.2.1 Global Microbial Alternative Protein Sales by Region: 2018-2023
3.2.2 Global Microbial Alternative Protein Sales by Region: 2024-2029
3.3 Global Microbial Alternative Protein Global Microbial Alternative Protein Revenue by Region: 2018-2029
3.3.1 Global Microbial Alternative Protein Revenue by Region: 2018-2023
3.3.2 Global Microbial Alternative Protein Revenue by Region: 2024-2029
3.4 North America Microbial Alternative Protein 麻豆原创 Facts & Figures by Country
3.4.1 North America Microbial Alternative Protein 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Microbial Alternative Protein Sales by Country (2018-2029)
3.4.3 North America Microbial Alternative Protein Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microbial Alternative Protein 麻豆原创 Facts & Figures by Country
3.5.1 Europe Microbial Alternative Protein 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Microbial Alternative Protein Sales by Country (2018-2029)
3.5.3 Europe Microbial Alternative Protein Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microbial Alternative Protein 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Microbial Alternative Protein 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Microbial Alternative Protein Sales by Country (2018-2029)
3.6.3 Asia Pacific Microbial Alternative Protein Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microbial Alternative Protein 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Microbial Alternative Protein 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Microbial Alternative Protein Sales by Country (2018-2029)
3.7.3 Latin America Microbial Alternative Protein Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microbial Alternative Protein 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Microbial Alternative Protein 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Microbial Alternative Protein Sales by Country (2018-2029)
3.8.3 Middle East and Africa Microbial Alternative Protein Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microbial Alternative Protein Sales by Type (2018-2029)
4.1.1 Global Microbial Alternative Protein Sales by Type (2018-2023)
4.1.2 Global Microbial Alternative Protein Sales by Type (2024-2029)
4.1.3 Global Microbial Alternative Protein Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Microbial Alternative Protein Revenue by Type (2018-2029)
4.2.1 Global Microbial Alternative Protein Revenue by Type (2018-2023)
4.2.2 Global Microbial Alternative Protein Revenue by Type (2024-2029)
4.2.3 Global Microbial Alternative Protein Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Microbial Alternative Protein Price by Type (2018-2029)
5 Segment by Application
5.1 Global Microbial Alternative Protein Sales by Application (2018-2029)
5.1.1 Global Microbial Alternative Protein Sales by Application (2018-2023)
5.1.2 Global Microbial Alternative Protein Sales by Application (2024-2029)
5.1.3 Global Microbial Alternative Protein Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Microbial Alternative Protein Revenue by Application (2018-2029)
5.2.1 Global Microbial Alternative Protein Revenue by Application (2018-2023)
5.2.2 Global Microbial Alternative Protein Revenue by Application (2024-2029)
5.2.3 Global Microbial Alternative Protein Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Microbial Alternative Protein Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AgriProtein (South Africa)
6.1.1 AgriProtein (South Africa) Corporation Information
6.1.2 AgriProtein (South Africa) Description and Business Overview
6.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AgriProtein (South Africa) Microbial Alternative Protein Product Portfolio
6.1.5 AgriProtein (South Africa) Recent Developments/Updates
6.2 Ynsect (France)
6.2.1 Ynsect (France) Corporation Information
6.2.2 Ynsect (France) Description and Business Overview
6.2.3 Ynsect (France) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ynsect (France) Microbial Alternative Protein Product Portfolio
6.2.5 Ynsect (France) Recent Developments/Updates
6.3 Enterra Feed Corporation (Canada)
6.3.1 Enterra Feed Corporation (Canada) Corporation Information
6.3.2 Enterra Feed Corporation (Canada) Description and Business Overview
6.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolio
6.3.5 Enterra Feed Corporation (Canada) Recent Developments/Updates
6.4 Protix (The Netherlands)
6.4.1 Protix (The Netherlands) Corporation Information
6.4.2 Protix (The Netherlands) Description and Business Overview
6.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Protix (The Netherlands) Microbial Alternative Protein Product Portfolio
6.4.5 Protix (The Netherlands) Recent Developments/Updates
6.5 Proti-Farm Holding NV (The Netherlands)
6.5.1 Proti-Farm Holding NV (The Netherlands) Corporation Information
6.5.2 Proti-Farm Holding NV (The Netherlands) Description and Business Overview
6.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolio
6.5.5 Proti-Farm Holding NV (The Netherlands) Recent Developments/Updates
6.6 Entomo Farms (Canada)
6.6.1 Entomo Farms (Canada) Corporation Information
6.6.2 Entomo Farms (Canada) Description and Business Overview
6.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Entomo Farms (Canada) Microbial Alternative Protein Product Portfolio
6.6.5 Entomo Farms (Canada) Recent Developments/Updates
6.7 Global Bugs Asia Co., Ltd. (Thailand)
6.6.1 Global Bugs Asia Co., Ltd. (Thailand) Corporation Information
6.6.2 Global Bugs Asia Co., Ltd. (Thailand) Description and Business Overview
6.6.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolio
6.7.5 Global Bugs Asia Co., Ltd. (Thailand) Recent Developments/Updates
6.8 Aspire Food Group (U.S.)
6.8.1 Aspire Food Group (U.S.) Corporation Information
6.8.2 Aspire Food Group (U.S.) Description and Business Overview
6.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolio
6.8.5 Aspire Food Group (U.S.) Recent Developments/Updates
6.9 Tiny Farms (U.S.)
6.9.1 Tiny Farms (U.S.) Corporation Information
6.9.2 Tiny Farms (U.S.) Description and Business Overview
6.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolio
6.9.5 Tiny Farms (U.S.) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microbial Alternative Protein Industry Chain Analysis
7.2 Microbial Alternative Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microbial Alternative Protein Production Mode & Process
7.4 Microbial Alternative Protein Sales and 麻豆原创ing
7.4.1 Microbial Alternative Protein Sales Channels
7.4.2 Microbial Alternative Protein Distributors
7.5 Microbial Alternative Protein Customers
8 Microbial Alternative Protein 麻豆原创 Dynamics
8.1 Microbial Alternative Protein Industry Trends
8.2 Microbial Alternative Protein 麻豆原创 Drivers
8.3 Microbial Alternative Protein 麻豆原创 Challenges
8.4 Microbial Alternative Protein 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AgriProtein (South Africa)
Ynsect (France)
Enterra Feed Corporation (Canada)
Protix (The Netherlands)
Proti-Farm Holding NV (The Netherlands)
Entomo Farms (Canada)
Global Bugs Asia Co., Ltd. (Thailand)
Aspire Food Group (U.S.)
Tiny Farms (U.S.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.